Bone injection for CT scans: tiny study tests safety
NCT ID NCT01531686
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This observational study looked at whether CT contrast dye can be safely and effectively delivered through a needle placed in the upper arm bone (intraosseous access) instead of a vein. Only 8 adults who already had such access were enrolled. The study was terminated early, so the findings are very limited.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- CT contrast dye delivered via intraosseous access
- What this could lead to
- If successful, this could show that injecting CT contrast dye through a bone (intraosseous) is a safe and effective option when IV access is not possible.
- What could go wrong
- This was a very small study (only 8 people) that was terminated early, so results are limited and may not apply broadly. The procedure carries risks like infection or dye leakage.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PATIENTS WITH INTRAOSSEOUS VASCULAR ACCESS REQUIRING COMPUTED TOMOGRAPHY (CT) EXAM are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Grand Strand Regional Medical
Myrtle Beach, South Carolina, 29572, United States
-
Maricopa Medical Center
Phoenix, Arizona, 85008, United States
-
Olive View UCLA Medical Center
Sylmar, California, 91342, United States
-
Shands Critical Care Center and Cancer Hospital
Gainesville, Florida, 32608, United States